Replies to post #94011 on Ayala Pharmaceuticals Inc (ADXS)

[fbg0316]

It's probably a combination of things, but it all points to the same thing, ADXS lost confidence that they investment would pay off, otherwise they would have continued with the partnership. Higher than expected manufacturing costs are probably part of it, but if you have a game changer that won't matter as much, so couple with concern on costs with the initial data which may have not Amgens expectations at that early stage, then the decision is attributed in the nice wrapper of "change of strategic direction".

[ignatiusrielly35]

Maybe you should listen to Dew and Hov, who know a lot more about it than anyone else. They both said it’s hogwash.